PRESS RELEASE PriZm Therapeutics is the winner of BIO’s 2023 Seed Stage Start-Up Stadium Pitch CHANDLER, AZ / September 25, 2023 / Out of the University of Miami, the industry’s first investigator-initiated emergency trial treating a pregnant mother has been authorized by the U.S. Food and Drug
Read more →